Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer
about
Nutritional risk assessment in critically ill cancer patients: systematic reviewInflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patientsProphylactic liver transplantation for high-risk recurrent hepatocellular carcinomaA laboratory prognostic index model for patients with advanced non-small cell lung cancerAssociation of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study.Prognostic factors for recurrence-free and overall survival after adrenalectomy for metastatic carcinoma: a retrospective cohort pilot study.Predictive value of the modified Glasgow Prognostic Score for the therapeutic effects of molecular-targeted drugs on advanced renal cell carcinoma.Inflammation-based score (Glasgow prognostic score) as an independent prognostic factor in colorectal cancer patients.Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer.Modified glasgow prognostic score in patients with small-cell lung cancerGlasgow prognostic score after concurrent chemoradiotherapy is a prognostic factor in advanced head and neck cancer.Identification of prognostic inflammatory factors in colorectal liver metastases.Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer.Patterns of use and tolerance of anti-epidermal growth factor receptor antibodies in older adults with metastatic colorectal cancer.The relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancer.The modified Glasgow Prognostic Scores as a predictor in diffuse large B cell lymphoma treated with R-CHOP regimen.Glasgow Prognostic Score (GPS) can be a useful indicator to determine prognosis of patients with colorectal carcinoma.Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review.Glasgow prognostic score in patients receiving chemotherapy for non-small-cell lung cancer in stages IIIb and IV.Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer.Age-independent rise of inflammatory scores may contribute to accelerated aging in multi-morbidity.Procalcitonin improves the Glasgow Prognostic Score for outcome prediction in emergency patients with cancer: a cohort study.The neutrophil to lymphocyte ratio can discriminate anaplastic thyroid cancer against poorly or well differentiated cancerSerum leptin levels in gastric cancer patients and the relationship with insulin resistance.The application of the Palliative Prognostic Index, charlson comorbidity index, and Glasgow Prognostic Score in predicting the life expectancy of patients with hematologic malignancies under palliative care.Simple and Objective Prediction of Survival in Patients with Lung Cancer: Staging the Host Systemic Inflammatory Response.The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patientsThe association of platelet count with clinicopathological significance and prognosis in renal cell carcinoma: a systematic review and meta-analysis.The prognostic value of pretreatment of systemic inflammatory responses in patients with urothelial carcinoma undergoing radical cystectomy.A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell CarcinomaPrognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: a multicenter studyAlbumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive CohortThe relationship between an inflammation-based prognostic score (Glasgow Prognostic Score) and changes in serum biochemical variables in patients with advanced lung and gastrointestinal cancer.Glasgow prognostic score predicts prognosis of non-small cell lung cancer: a meta-analysisClinical and prognostic significance of pathological and inflammatory markers in the surgical treatment of locally advanced colorectal cancerThe Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung CancerSystemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal AdenocarcinomaEvaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer.Impact of systemic inflammation on gastric cancer outcomes.Prognostic significance of Glasgow prognostic score in patients with stage II colorectal cancer.
P2860
Q26798173-F98D1603-387B-432A-AEAB-DE6D5BEC2F5BQ27009534-86740817-9B45-4E1E-961F-CA8480EE8E21Q28073769-DDAE2C86-7D65-4A99-9382-39277093BA6EQ28542513-C9DAAF3D-4299-4A91-B0CE-6586B6CE543DQ33532808-2CA1830D-0802-4D5A-A1B3-76BCB55745A8Q33673109-77E4A25F-6CFF-4B81-A33C-F233881FF163Q33684941-D5E0F339-F15D-49E9-9BD4-F1FDDDA0DEB0Q33773692-89F373F8-AC43-46A0-84ED-566B8D4E8D13Q33783059-616E7E55-0501-46DC-90B2-0115A24BAA83Q33857754-B8F79853-E7C0-4889-A5DA-25A216F2BC0DQ33871869-C9316FEB-3035-4A8D-A1C3-4A359CA4DC82Q34017917-CF2A600B-0232-48D3-BA99-3D8FA1E28903Q34079559-C95B2329-1EFB-4ACD-9D30-F423161027F1Q34173277-2C2ED9A2-5FE2-4317-9354-2B0BB02C1FCDQ34344152-E817668D-BDB1-40A3-9BF7-7C2FCB9D96B2Q34384335-908C4FAB-49B9-49FD-8A79-DA841FD565A5Q34621908-67DAA9E7-9F31-432B-AD73-4B207FD8FA1CQ34636595-6B95E611-99A0-4C4E-8998-A83ED9F68F47Q34746166-58806B2D-7A9F-4D1A-997C-F1910FA5FDDFQ34806672-8B396524-7C43-4269-A5EF-A1F87670B225Q35176319-EDAA878A-A0D4-4B39-8197-8399394917FCQ35226677-2F034A84-5C2A-460B-8451-AACB4C8EF8CDQ35257367-35F68347-52B7-4224-80EF-C3B8CC4246D2Q35582841-2F69E0C7-9B20-4519-99FB-761EAACA1901Q35601183-F7845F68-5A2C-4AFA-93E1-AEAB8525E445Q35623609-5DAC30C4-E8B9-47E3-B8B0-B28CC6E6778DQ35624432-E1F0FC91-F57F-4128-8388-B36AD623C995Q35625163-BE8E3446-FDC2-4C92-A760-502BF0FC4371Q35677849-F884F7ED-D7C8-455A-BF66-B400D4C12D1AQ35781911-2EAD9CE4-5569-4598-A66D-9D0AD2952836Q35791350-BAC2EB5B-E55A-4539-BE53-00232EDD0DE4Q35866244-A935E4B1-D2C2-464D-AEEB-C85358A65A34Q35954348-ED90FE73-4A17-41C5-9E3D-8EE0F928BFCDQ35996748-6E9E9F17-7AE7-4FF1-BE73-47B65EFBE56AQ36036860-D4AF7426-76E4-4566-83E4-92FE479937B7Q36107012-EC737674-FB0A-4C3D-9B83-9CDF35651ED2Q36134440-9FB91675-D4FF-4349-BC7C-F4CD4E03D803Q36230435-6C5D0F18-0EBC-4B9B-AF91-4DC9D5774398Q36328544-A891B4C2-46F6-4A2E-BDF6-FA5259BF8C6FQ36412149-4FB77FAC-822F-4846-B842-3B708079F7AA
P2860
Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Evaluation of cumulative progn ...... ble non-small-cell lung cancer
@ast
Evaluation of cumulative progn ...... ble non-small-cell lung cancer
@en
type
label
Evaluation of cumulative progn ...... ble non-small-cell lung cancer
@ast
Evaluation of cumulative progn ...... ble non-small-cell lung cancer
@en
prefLabel
Evaluation of cumulative progn ...... ble non-small-cell lung cancer
@ast
Evaluation of cumulative progn ...... ble non-small-cell lung cancer
@en
P2093
P2860
P356
P1476
Evaluation of cumulative progn ...... ble non-small-cell lung cancer
@en
P2093
Angerson WJ
Forrest LM
McArdle CS
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601242
P407
P577
2003-09-01T00:00:00Z